Join Dr. Amy Armstrong and me on 4/29 at #ASPHO2026—in Minneapolis or virtually—as we explore practical strategies to improve outcomes for patients with NF1-PNs. Register with @PeerView: bit.ly/NF26-T #MedEd #Oncology
Angela Hirbe retweeted
Incredible time for the Francis Collins Scholars community! Our 7 summer interns shared powerful NF1 research on MPNST, optic gliomas, GI symptoms & neuropsychiatric profiles. Huge thanks to mentors & supporters! #FrancisCollinsScholars #NFResearch
Angela Hirbe retweeted
Congrats to Guangfeng Wang from @AngelaHirbe Lab @SitemanCenter for receiving the Neurogenetic Tumor Syndrome Abstract Award at #SNO2024!! #NF1 #MPNST
Angela Hirbe retweeted
#SNO2024: @washumedicine neuro-oncologists and researchers at Siteman, including @Corina_Anast, @AngelaHirbe, and Omar Butt, MD, PhD present today.
Check out the conference details here: soc-neuro-onc.org/SNOAnnualM…
@WashuMedBTC
@NeuroOnc
Angela Hirbe retweeted
So thankful for @ChildrensTumor’s incredible support that made our most recent publication possible (shorturl.at/amWS2; #tweetorial xitter.cf/rtsundby/status/183171…). With @ChildrensTumor we are now working towards moving our findings from research to the clinic, stay tuned! #endNF
MAJOR BIOMARKER PROJECT TO HELP IDENTIFY CANCER PREDISPOSITION IN NF1 PATIENTS
NF Funders Collaborate So That Great Science Never Stops: ctf.org/news/major-biomarker…
#endnf #nfresearch #makenfvisible #cancer #cancerresearch #mpnst #nf1 #neurofibromatosis
Angela Hirbe retweeted
So proud to present our poster at #CTF24. I’ve met incredible people, so happy to be in this #NF community! Special thanks to my mentor @AngelaHirbe, sweetest person alive! #endnf #makenfvisible @ChildrensTumor
Angela Hirbe retweeted
It was a huge privilege to co-lead the #liquidbx team with @PughLab. There are immense scientific + clinical opportunities w/ motivated multi-disciplinary teams working on them. I have no doubt that huge strides will be made in #NF1 care through #collaboration & #openscience!
The #NF1 Nerve Sheath Tumor Biomarker Development Symposium brought together creative thinkers and powerful do-ers to identify the most promising liquid, tissue, imaging and digital records markers to inform therapeutics for #NF1 tumors.
Learn more: bit.ly/3Ra01BQ
Angela Hirbe retweeted
Lucky to have amazing colleagues and collaborators like @NCIResearchCtr-@NCIResearchCtr’s @DrXiyuanZhang who presented amazing work using scRNAseq data to inform and improve clinical care! @ChildrensTumor #CTF2024 #endNF
Angela Hirbe retweeted
Exciting talk by @sargoshoe Gosline from PNNL on using model systems data to enable AI assisted drug response predictions … @ChildrensTumor #EndNF #NFcon24
Also.. cool enough to wear a party hat to celebrate a friends birthday 🥳 well done Dr Gosline !
Angela Hirbe retweeted
@NCI_CCR_PedOnc’s all-star post-bac Omar Roman presents ground breaking work on the effect of selumetinib holds/interruptions on PN growth. Poster competition winter ➡️ platform talk with practice changing potential! @ChildrensTumor #CTF2024 #endNF
Angela Hirbe retweeted
A delightful time catching up with 10 of NTAP’s 18 Francis S. Collins Scholars & their mentors while in Brussels @ChildrensTumor. Thank you all for your dedication to moving the needle in NF1 research! #NFCON24 #endNF
Angela Hirbe retweeted
Powerhouse panel! @SARCtrials hosting a review of SARC028 data on #ICI in #sarcoma - followed by a cage fight / debate on TLS as a biomarker!
Moderated by the unmatched @sandrapdangelo
Angela Hirbe retweeted
Pre/postop pembro + preop RT ➡️📈DFS vs. preop RT alone (70 v. 53%) for select G2/G3 resectable, extremity sarcomas (UPS + LPS), benefit namely in G3: tiny.cc/SARC032 @DKirschMDPhD @richardriedelmd @bvantine1 @SARCtrials @DanaFarberNews @DanaFarber @DrVinayakV#ASCO24
Angela Hirbe retweeted
@AngelaHirbe @WashUOnc @WUSTLdbbs @WUDeptMedicine
Angela Hirbe retweeted
Really impressive session for #mpnst #asco24 - so much work done but still need new therapies great summary by @AngelaHirbe
Angela Hirbe retweeted
It was a blast writing a chapter on updated approaches to #MPNST #sarcoma with @carina_dehner, Dombi, Eulo, Gross, Lazar and lead @AngelaHirbe for the @ASCO education book. Check it out doi.org/10.1200/EDBK_432242 and don’t miss the paired #ASCO2024 panel 5/31 4:30p S102! #ENDNF
Angela Hirbe retweeted
Saying goodbye to an amazing two years at @WUSTLmed 🥂Feeling incredibly fortunate to have @AngelaHirbe as a mentor on this journey! ❤️
Angela Hirbe retweeted
Shout out to co-authors @AngelaHirbe @jack_shern @aadel_chaudhuri as well as twitterless Jeff Szymanski & Paul Jones. And thank you to @ntapresearch & @ChildrensTumor for supporting our work towards this goal in the cancer predisposition #NF1! #childhoodcancer #cancerprevention
Angela Hirbe retweeted
In @ASCO’s Daily News our @NCI_CCR_PedOnc-@WUSTLmed -@MayoClinic #collaboration discuss the transformative potential for #cfDNA #liquidbx in hereditary cancer syndrome surveillance. We highlight strives by @landau_lab, @PughLab and others towards this 🥅
dailynews.ascopubs.org/do/un…
Angela Hirbe retweeted
Looking forward to #FrancisSCollinsScholar Dr. Chelsea Kotch’s talk on risk stratification for #NF1 associated tumors at the Pediatric Precision Medicine Cancer Care Summit hosted by UCSF next week! More info here:
virtualce.ucsf.edu/Pediatric…
#NF @HopkinsMedicine @NTAPresearch
